Society for Immunotherapy of Cancer (SITC) Symposium

 Saturday, May 7, 2022     12:30 PM – 2:30 PM ET     Oregon Ballroom 204

Society for Immunotherapy of Cancer (SITC) Symposium

Understanding the Tumor-Reactive T Cell Repertoire in Cancer Patients

Chairs

• Andrew D. Weinberg, Earle A. Chiles Res. Inst., Providence Portland Med. Ctr.
• Paul F. Robbins, NCI, NIH

Speakers

• Andrew D. Weinberg, Earle A. Chiles Res. Inst., Providence Portland Med. Ctr., Identifying tumor-reactive CD8⁺ TIL in patients with solid malignancies: clinical implications
• Kathryn E. Yost, Whitehead Inst., Clonal dynamics of tumor-infiltrating T cells in response to checkpoint blockade immunotherapy
• Alena Gros, Vall d'Hebron Inst. of Oncology, Spain, Harnessing the personalized antitumor T cell response to treat cancer
• Paul F. Robbins, NCI, NIH, Isolating and characterizing neo-antigen reactive T cells in patients with solid tumors